Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies
- 31 March 2004
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 92 (3) , 367-373
- https://doi.org/10.1016/s1081-1206(10)61576-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Interpreting atmospheric pollen counts for use in clinical allergy: allergic symptomologyAnnals of Allergy, Asthma & Immunology, 2001
- Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic AsthmaA Multicenter, Randomized, Double-blind TrialArchives of internal medicine (1960), 1998
- Montelukast for Chronic Asthma in 6- to 14-Year-Old ChildrenJAMA, 1998
- Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC)Pediatric Allergy and Immunology, 1997
- Prevalence of allergic rhinitis in the United StatesJournal of Allergy and Clinical Immunology, 1997
- Correlations between Complaints, Inflammatory Cells and Mediator Concentrations in Nasal Secretions after Nasal Allergen Challenge and during Natural Allergen ExposureInternational Archives of Allergy and Immunology, 1995
- Rhinitis and asthmaJAMA, 1992
- Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive childrenJournal of Allergy and Clinical Immunology, 1988
- Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humansClinical and Experimental Allergy, 1986
- Allergen‐Induced Release of Sulphidopeptide Leukotrienes (SRS‐A) and LTB4 in Allergic RhinitisAllergy, 1985